BMY - Bristol-Myers Squibb Company

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 578.14B
Enterprise Value 374.18B
Trailing P/E 12.58
Forward P/E 110.81
PEG Ratio (5 yr expected) 12.51
Price/Sales (ttm)3.28
Price/Book (mrq)4.87
Enterprise Value/Revenue 33.11
Enterprise Value/EBITDA 69.69

Trading Information

Stock Price History

Beta (3Y Monthly) 0.71
52-Week Change 3-21.64%
S&P500 52-Week Change 31.35%
52 Week High 363.69
52 Week Low 342.48
50-Day Moving Average 345.35
200-Day Moving Average 347.36

Share Statistics

Avg Vol (3 month) 313.21M
Avg Vol (10 day) 39.57M
Shares Outstanding 51.63B
Float 1.63B
% Held by Insiders 10.11%
% Held by Institutions 175.05%
Shares Short (Jul 31, 2019) 4124.02M
Short Ratio (Jul 31, 2019) 48.96
Short % of Float (Jul 31, 2019) 47.59%
Short % of Shares Outstanding (Jul 31, 2019) 47.58%
Shares Short (prior month Jun 28, 2019) 4111.32M

Dividends & Splits

Forward Annual Dividend Rate 41.64
Forward Annual Dividend Yield 43.44%
Trailing Annual Dividend Rate 31.63
Trailing Annual Dividend Yield 33.43%
5 Year Average Dividend Yield 42.66
Payout Ratio 443.01%
Dividend Date 3Aug 1, 2019
Ex-Dividend Date 4Jul 3, 2019
Last Split Factor (new per old) 2951777/1000000
Last Split Date 3Aug 7, 2001

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 26.00%
Operating Margin (ttm)29.59%

Management Effectiveness

Return on Assets (ttm)10.05%
Return on Equity (ttm)43.57%

Income Statement

Revenue (ttm)23.86B
Revenue Per Share (ttm)14.60
Quarterly Revenue Growth (yoy)10.00%
Gross Profit (ttm)16.07B
Net Income Avi to Common (ttm)6.2B
Diluted EPS (ttm)3.80
Quarterly Earnings Growth (yoy)283.90%

Balance Sheet

Total Cash (mrq)29.36B
Total Cash Per Share (mrq)17.95
Total Debt (mrq)25.8B
Total Debt/Equity (mrq)159.75
Current Ratio (mrq)3.88
Book Value Per Share (mrq)9.81

Cash Flow Statement

Operating Cash Flow (ttm)7.18B
Levered Free Cash Flow (ttm)4.29B